Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 08/25 10:00:00 pm
71.74 USD   -6.03%
08/25 NASDAQ 100 MOVE : Dltr, mu
08/24 LAWSUIT FOR LON : ESRX) Filed
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/19/2016 08/22/2016 08/23/2016 08/24/2016 08/25/2016 Date
76.38(c) 76.51(c) 77.15(c) 76.34(c) 71.74(c) Last
2 525 759 2 309 646 4 868 025 3 042 017 13 815 591 Volume
-0.31% +0.17% +0.84% -1.05% -6.03% Change
More quotes
Financials ($)
Sales 2016 101 827 M
EBIT 2016 6 532 M
Net income 2016 2 912 M
Debt 2016 12 635 M
Yield 2016 -
Sales 2017 104 506 M
EBIT 2017 6 615 M
Net income 2017 3 094 M
Debt 2017 10 804 M
Yield 2017 -
P/E ratio 2016 15,65
P/E ratio 2017 14,19
EV / Sales2016 0,57x
EV / Sales2017 0,54x
Capitalization 45 212 M
More Financials
Company
Express Scripts Holding Co. engages in the provision of integrated pharmacy benefit management services.Its services include network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, benefit-design consultation, drug utilization review, formulary management, and... 
Sector
Drug Retailers
Calendar
10/25Earnings Release
More about the company
Surperformance© ratings of Express Scripts Holding Co
Trading Rating : Investor Rating :
More Ratings
Latest news on EXPRESS SCRIPTS HOLDING CO
08/25 NASDAQ 100 MOVERS : Dltr, mu
08/24 LAWSUIT FOR LONG-TERM INVESTORS IN S : ESRX) Filed
More news
Sector news : Drug Retailers - NEC
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/17DJTarget Dims Outlook as Sales Struggle
08/09DJPatient Survey Company Press Ganey to Sell Itself to Swedish Firm EQT
08/09DJValeant Posts a Loss and Says It Will Retool
08/05DJAbbVie Sues Amgen Over Humira
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2016 Updat..
08/23 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2016 Upda..
08/12 DIPLOMAT PHARMACY : The Correction Seems Overdone, Overlooking The Performance
08/11 7 INTRIGUING HEALTHCARE GROWTH STOCK : Part 2
08/03 BIOTECH DAILY DIGEST : A Buyout For Biogen? The Rally Continues. Spotlight On Li..
Advertisement
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 82,1 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-17.93%48 111
CVS HEALTH CORP-4.08%103 604
WALGREENS BOOTS ALLIAN..-5.84%88 176
MCKESSON CORPORATION-7.06%42 669
CARDINAL HEALTH INC-11.10%25 831
AMERISOURCEBERGEN CORP..-17.55%18 980
More Results